Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,746 | 51,692 | 36,053 | 25,574 | 32,786 |
| Marketable Securities | 20,575 | 9,422 | 13,049 | 23,976 | 24,147 |
| Receivables | 41,615 | 30,575 | 28,904 | 27,512 | 30,550 |
| Inventories | 6,002 | 4,784 | 8,059 | 6,579 | 5,522 |
| TOTAL | $135,103 | $106,467 | $94,723 | $92,486 | $99,266 |
| Non-Current Assets | |||||
| PPE Net | N/A | 99 | 115 | 140 | 165 |
| Intangibles | 27,100 | 27,687 | 28,275 | 28,863 | 13,878 |
| Other Non-Current Assets | 1,773 | 5,166 | 5,295 | 5,030 | 3,916 |
| TOTAL | $28,873 | $32,952 | $33,685 | $34,033 | $17,959 |
| Total Assets | $163,976 | $139,419 | $128,408 | $126,519 | $117,225 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,339 | 3,815 | 6,130 | 9,276 | 7,142 |
| Accrued Expenses | 14,212 | 11,517 | 11,045 | 9,373 | 12,189 |
| Other current liabilities | 38,191 | 27,192 | 33,547 | 32,270 | 19,326 |
| TOTAL | $63,299 | $54,312 | $58,649 | $73,198 | $53,267 |
| Non-Current Liabilities | |||||
| Long Term Debt | 52,408 | 59,762 | 59,692 | 44,910 | 52,373 |
| Deferred Revenues | N/A | 1,355 | 1,355 | 1,355 | 1,355 |
| Other Non-Current Liabilities | 44,981 | 39,981 | 39,981 | 39,982 | 40,229 |
| TOTAL | $97,389 | $99,743 | $99,673 | $84,992 | $92,602 |
| Total Liabilities | $160,688 | $154,055 | $158,322 | $158,190 | $145,869 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,863 | 17,615 | 17,595 | 17,541 | 17,538 |
| Common Shares | 18 | 17 | 17 | 175 | 17 |
| Retained earnings | -1,390,065 | -1,404,406 | -1,416,827 | -1,415,797 | -1,407,550 |
| Other shareholders' equity | 10 | 11 | -9 | -5 | 8 |
| TOTAL | $3,288 | $-14,636 | $-29,914 | $-31,671 | $-28,644 |
| Total Liabilities And Equity | $163,976 | $139,419 | $128,408 | $126,519 | $117,225 |